Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012/9456

Reversing ventricular remodeling represents a promising treatment for the post-myocardial infarction (MI) heart failure (HF). Here, we report a novel small molecule HHQ16, an optimized derivative of astragaloside IV, which effectively reversed infarction-induced myocardial remodeling and improved ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Jingjing, Zhang, Zhen, Wu, Chennan, Tian, Saisai, Zang, Yibei, Jin, Ge, Sun, Qingyan, Wang, Pin, Luan, Xin, Yang, Yili, Zhan, Xuelin, Ye, Lingyu Linda, Duan, Dayue Darrel, Liu, Xia, Zhang, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587311/
https://www.ncbi.nlm.nih.gov/pubmed/37857609
http://dx.doi.org/10.1038/s41392-023-01660-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587311/
https://www.ncbi.nlm.nih.gov/pubmed/37857609
http://dx.doi.org/10.1038/s41392-023-01660-9

Ejemplares similares